Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management von Vora, Jiten, Cherney, David, Kosiborod, Mikhail N., Spaak, Jonas, Kanumilli, Naresh, Khunti, Kamlesh, Lam, Carolyn S. P., Bachmann, Michael, Fenici, Peter

Volltext

Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial von Butler, Javed, Anker, Stefan D., Siddiqi, Tariq Jamal, Coats, Andrew J. S., Dorigotti, Fabio, Filippatos, Gerasimos, Friede, Tim, Göhring, Udo‐Michael, Kosiborod, Mikhail N., Lund, Lars H., Metra, Marco, Moreno Quinn, Carol, Piña, Ileana L., Pinto, Fausto J., Rossignol, Patrick, Szecsödy, Peter, Van Der Meer, Peter, Weir, Matthew, Pitt, Bertram

Volltext

Lower risk of cardiovascular events and death associated with initiation of sodium‐glucose cotransporter‐2 inhibitors versus sulphonylureas: Analysis from the CVD‐REAL 2 study... von Goh, Su‐Yen, Kosiborod, Mikhail N., Lam, Carolyn S. P., Cavender, Matthew A., Kohsaka, Shun, Norhammar, Anna, Birkeland, Kåre I., Holl, Reinhard W., Mauricio, Dídac, Tangri, Navdeep, Shaw, Jonathan E., Thuresson, Marcus, Fenici, Peter, Kim, Dae Jung

Volltext

Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF von Bhatt, AS, Bhatt, DL, Steg, G, Szarek, M, Cannon, CP, Leiter, LA, McGuire, DK, Lewis, JB, Riddle, MC, Voors, AA, Metra, M, Lund, LH, Testani, JM, Wilcox, CS, Davies, M, Pitt, B, Kosiborod, MN

Volltext

Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease von Rossignol, P., Silva-Cardoso, J., Kosiborod, MN, Brandenburg, V., Cleland, JG, Hadimeri, H., Hullin, R., Makela, S., Mörtl, D., Paoletti, E., Pollock, C., Vogt, L., Jadoul, M., Butler, J.

Volltext

Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia von Pitt, B, Anker, SD, Lund, LH, Coats, AJS, Filippatos, G, Rossignol, P, Weir, MR, Friede, T, Kosiborod, MN, Metra, M, Bohm, M, Ezekowitz, JA, Bayes-Genis, A, Mentz, RJ, Ponikowski, P, Senni, M, Pina, IL, Pinto, FJ, van der Meer, P, Bahit, C, Belohlavek, J, Brugts, JJ, Perrin, A, Waechter, S, Budden, J, Butler, J

Volltext

Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF von Pitt, Bertram, Bhatt, Deepak L, Szarek, Michael, Cannon, Christopher P, Leiter, Lawrence A, McGuire, Darren K, Lewis, Julia B, Riddle, Matthew C, Voors, Adriaan A, Metra, Marco, Lund, Lars H, Komajda, Michel, Testani, Jeffrey M, Wilcox, Christopher S, Ponikowski, Piotr, Lopes, Renato D, Ezekowitz, Justin A, Sun, Franklin, Davies, Michael J, Verma, Subodh, Kosiborod, Mikhail N, Steg, Ph Gabriel

Volltext

Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility von James, Glen, Garcia Sanchez, Juan Jose, Carrero, Juan Jesus, Kumar, Supriya, Pecoits-Filho, Roberto, Heerspink, Hiddo J.L., Nolan, Stephen, Lam, Carolyn S.P., Chen, Hungta, Kanda, Eiichiro, Kashihara, Naoki, Arnold, Matthew, Kosiborod, Mikhail N., Lainscak, Mitja, Pollock, Carol, Wheeler, David C.

Volltext

Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort von Fishbane, Steven, Carrero, Juan-Jesus, Kumar, Supriya, Kanda, Eiichiro, Hedman, Katarina, Ofori-Asenso, Richard, Kashihara, Naoki, Kosiborod, Mikhail N, Lainscak, Mitja, Pollock, Carol, Stenvinkel, Peter, Wheeler, David C, Pecoits-Filho, Roberto

Volltext

Diabetes-related factors and the effects of Ticagrelor Plus aspirin in the THEMIS and THEMIS-PCI trials von Leiter, L, Bhatt, DL, McGuire, DK, Teoh, H, Fox, K, Simon, T, Mehta, SR, Lev, EI, Kiss, RG, Dalby, AJ, Bueno, H, Ridderstrale, W, Himmelmann, A, Prats, J, Liu, Y, Lee, JL, Amerena, J, Kosiborod, MN, Steg, PG

Volltext

Sotagliflozin in patients with diabetes and chronic kidney disease von Bhatt, DL, Szarek, M, Pitt, B, Cannon, CP, Leiter, LA, McGuire, DK, Lewis, JB, Riddle, MC, Inzucchi, SE, Kosiborod, MN, Cherney, DZI, Dwyer, JP, Scirica, BM, Bailey, CJ, Díaz, R, Ray, KK, Udell, JA, Lopes, RD, Lapuerta, P, Steg, PG, SCORED Investigators

Volltext

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, r... von Bhatt, DL, Steg, PG, Mehta, SR, Leiter, LA, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, SK, Ray, KK, Parkhomenko, AN, Kosiborod, MN, McGuire, DK, Harrington, RA, THEMIS Steering Committee and Investigators

Volltext

Correction von Pitt, B, Bhatt, DL, Szarek, M, Cannon, CP, Leiter, LA, Mcguire, DK, Lewis, JB, Riddle, MC, Voors, AA, Metra, M, Lund, LH, Komajda, M, Testani, JM, Wilcox, CS, Ponikowski, P, Lopes, RD, Ezekowitz, JA, Sun, F, Davies, MJ, Verma, S, Kosiborod, MN, Steg, PG

Volltext

Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility von James, G, Garcia Sanchez, JJ, Carrero, JJ, Kumar, S, Pecoits-Filho, R, Heerspink, HJL, Nolan, S, Lam, CSP, Chen, H, Kanda, E, Kashihara, N, Arnold, M, Kosiborod, MN, Lainscak, M, Pollock, C, Wheeler, DC

Volltext bestellen

Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials von Rossing, P, Inzucchi, SE, Vart, P, Jongs, N, Docherty, KF, Jhund, PS, Kober, L, Kosiborod, MN, Martinez, FA, Ponikowski, P, Sabatine, MS, Solomon, SD, DeMets, DL, Bengtsson, O, Lindberg, M, Langkilde, AM, Sjostrand, M, Stefansson, B, Karlsson, C, Chertow, GM, Hou, FF, Correa-Rotter, R, Toto, RD, Wheeler, DC, McMurray, JJ, Heerspink, HJL

Volltext bestellen